These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1620291)

  • 1. Sustained release of nerve growth factor from biodegradable polymer microspheres.
    Camarata PJ; Suryanarayanan R; Turner DA; Parker RG; Ebner TJ
    Neurosurgery; 1992 Mar; 30(3):313-9. PubMed ID: 1620291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyphosphoester microspheres for sustained release of biologically active nerve growth factor.
    Xu X; Yu H; Gao S; Ma HQ; Leong KW; Wang S
    Biomaterials; 2002 Sep; 23(17):3765-72. PubMed ID: 12109702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophin releasing single and multiple lumen nerve conduits.
    Yang Y; De Laporte L; Rives CB; Jang JH; Lin WC; Shull KR; Shea LD
    J Control Release; 2005 Jun; 104(3):433-46. PubMed ID: 15911044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders.
    Cao X; Schoichet MS
    Biomaterials; 1999 Feb; 20(4):329-39. PubMed ID: 10048405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel drug delivering conduit for peripheral nerve regeneration.
    Labroo P; Shea J; Edwards K; Ho S; Davis B; Sant H; Goodwin I; Gale B; Agarwal J
    J Neural Eng; 2017 Dec; 14(6):066011. PubMed ID: 28829045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic activity of nerve growth factor slowly released from microspheres.
    Hadlock TA; Sheahan T; Cheney ML; Vacanti JP; Sundback CA
    J Reconstr Microsurg; 2003 Apr; 19(3):179-84; discussion 185-6. PubMed ID: 12806579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of coencapsulated NGF and GM1 in rats with cortical lesions.
    Maysinger D; Filipovic-Grcic J; Cuello AC
    Neuroreport; 1993 Jul; 4(7):971-4. PubMed ID: 8369492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of brain derived neurotrophic factor released from microspheres.
    Mittal S; Cohen A; Maysinger D
    Neuroreport; 1994 Dec; 5(18):2577-82. PubMed ID: 7696608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining growth factor releasing microspheres within aligned nanofibers enhances neurite outgrowth.
    Whitehead TJ; Avila COC; Sundararaghavan HG
    J Biomed Mater Res A; 2018 Jan; 106(1):17-25. PubMed ID: 28879680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?
    Péan JM; Boury F; Venier-Julienne MC; Menei P; Proust JE; Benoit JP
    Pharm Res; 1999 Aug; 16(8):1294-9. PubMed ID: 10468034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of nerve growth factor in controlled release polymers and in tissue.
    Krewson CE; Dause R; Mak M; Saltzman WM
    J Biomater Sci Polym Ed; 1996; 8(2):103-17. PubMed ID: 8957707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo release of nerve growth factor from biodegradable poly-lactic-co-glycolic-acid microspheres.
    de Boer R; Knight AM; Spinner RJ; Malessy MJ; Yaszemski MJ; Windebank AJ
    J Biomed Mater Res A; 2010 Dec; 95(4):1067-73. PubMed ID: 20878933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres.
    Faranesh AZ; Nastley MT; Perez de la Cruz C; Haller MF; Laquerriere P; Leong KW; McVeigh ER
    Magn Reson Med; 2004 Jun; 51(6):1265-71. PubMed ID: 15170848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage.
    Menei P; Pean JM; Nerrière-Daguin V; Jollivet C; Brachet P; Benoit JP
    Exp Neurol; 2000 Jan; 161(1):259-72. PubMed ID: 10683292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve guidance channels as drug delivery vehicles.
    Piotrowicz A; Shoichet MS
    Biomaterials; 2006 Mar; 27(9):2018-27. PubMed ID: 16239029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres.
    Curley J; Castillo J; Hotz J; Uezono M; Hernandez S; Lim JO; Tigner J; Chasin M; Langer R; Berde C
    Anesthesiology; 1996 Jun; 84(6):1401-10. PubMed ID: 8669682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release.
    Goraltchouk A; Scanga V; Morshead CM; Shoichet MS
    J Control Release; 2006 Jan; 110(2):400-407. PubMed ID: 16325953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged controlled delivery of nerve growth factor using porous silicon nanostructures.
    Zilony N; Rosenberg M; Holtzman L; Schori H; Shefi O; Segal E
    J Control Release; 2017 Jul; 257():51-59. PubMed ID: 27988302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.
    Saltzman WM; Mak MW; Mahoney MJ; Duenas ET; Cleland JL
    Pharm Res; 1999 Feb; 16(2):232-40. PubMed ID: 10100308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor.
    Muir D
    Exp Cell Res; 1994 Feb; 210(2):243-52. PubMed ID: 8299723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.